Pardoprunox Hydrochloride

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePardoprunox Hydrochloride
Drug Alias Name帕多芦诺帕多卢诺SLV-308SME-308DU-126891
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D3 receptor agonistsSerotonin 1a (5-HT1a) receptor agonistsDopamine D2 receptor agonists
TargetsSerotonin 1a (5-HT1a) receptorDopamine D2 receptorDopamine D3 receptor
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[37] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott ProductsSolvay Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG